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The idea of Assisted Reproduction 
Technology (ART) (which at the 
moment is the highest break-through 
in the medical  treatment of infertility)  
in a resource- limited setting, sends a 
contradictory wave of thoughts as  to 
the desirability and affordability with 
such limited resources because of the 
high cost implication.  Usually, 
resource- limited settings refer to low 
income countries, who are still 
contending will basic developmental 
issues like poverty, high 
unemployment, high proportion of ill 
health in the populace, over population 
and poor infrastructure1 .   ART cost 
several thousands of Euro/dollars in 
high income countries where it is often 
a part of the spectrum of management 
of infertility which is both preventive 
and curable.  In low income countries, 
infertility is only one of the many 
important health problems that people 
face and ART being of such high cost, 
cannot be a considered method for 
infertility treatment in view of the 
serious competing demand on the 
limited resources.  It is often 
emphasized that the main issue in the 
resource limited setting is over 
population crisis rather than infertility 
whose management for now should be 
by the much cheaper preventive 
approaches2-4. 
The  issue of whether or not ART is 
worth considering at all, for infertility 
management, in resource limited 
settings, should not be wished away 
with the reinstatement that infertility 
prevention should be the emphasis 
while the limited resources, should be 
reserved for solving the over 
population crisis.  Such an approach is 
rather simplistic and devoid of the 
knowledge of the premium placed on 
child bearing in the socio-cultural 
setting of the people, in these resource 
limited countries.  While the people 
can easily cope with overpopulation at 
the individual level, because of the 
socio cultural care for each other, they 
cannot cope with infertility.  The 
individual, society and communities 
are devasted completely by infertility or 
childlessness.  
In Western societies, reproduction is 
often  a self chosen goal and largely a 
personal choice made by the individual 
or couple, hence infertility  is often a 
problem at the individual level without 
societal implications5 Infact, there are 
situations in Western societies, where 
couple decide not have children in 
their marriage. In the developing 
countries, having children is a social 
obligation, a performance due to the 
 
 
family (in laws) and whole community.   
Children secure marriage, confer 
social status, guarantee rights of 
property and inheritance, assist with 
labour, offer social security in old age 
and provide continuity of maintaining   
family name6-8. The main reason for 
marriage is for child bearing and not 
love as it is in Western countries.  
Often, there are no prior love plays or 
even familiarity between individuals in 
the marriage which is organised and 
sponsored by the families, society and 
community.  It is only childbirth that 
secures the marriage union and bind 
families and communities together.   
There can never be a marriage in the 
developing countries in which the 
couple decide on voluntary 
childlessness.  Thus, infertility in the 
developing countries is  pervasive and 
a serious concern especially to the 
woman leading on to  marital 
disharmony, neglect, abuse, loss of 
social security, polygamy and even 
suicide9-11.   
 Infertility in the developing countries is 
therefore, not just a desire at the level 
of the individual (as it is in western 
culture).  It is a huge disease burden 
with devastating consequences on the 
individual and society that deserve 
priority resolve amongst other disease 
chain12.  This is why infertility 
management should extend beyond 
prevention to include comprehensive 
treatment or else those presently 
afflicted with the disease will never be 
helped.  Even at this, it is feared that 
extending infertility treatment to 
include ART in resource limited 
settings may be impracticable, for 
reasons of unstable infrastructure, 
poor staff morale and poor maintance 
culture2-4. This is why it is assumed 
paradoxical to contemplate ART is in a 
resource limited setting with such 
obvious constrains. 
This review shall include a detailed 
description of ART and the present 
day indications.  The pattern of 
infertility in the developing countries is 
critically reviewed against the 
background knowledge of current 
socio cultural correlates of infertility in 
a resource-limited setting to assess 
the need for ART for infertility 
management.  Finally, the review shall 
present the outcome of ART in a 
resource limited setting like Nigeria 
with emphasis on the practice, 
prospects and future development of 
infertility management in developing 
countries. 
 
Assisted Reproduction Technology 
(ART) Basic Knowledge  
Assisted reproduction technology 
encompasses several techniques to 
by-pass the problems preventing 
conception through the normal sexual 
intercourse in a stable relationship.  
These techniques involve either 
artificial insemination or artificial 
fertilisation in which there is alteration 
in the inherent process leading unto 
conception and without sexual 
intercourse.  There are several types 
of ART presently viz: 
 
In vitro fertilization and Embryo 
Transfer (IVF and ET) 
This refers to the assemblage of 
procedure culminating in the retrieval 
of human Oocyte which is 
approximated to  potentiated Sperms 
in a test tube (In vitro) in a laboratory 
condition equilibrated  to the  same 
physiological condition as obtains  in 
the normal human environment  (in 
vivo).   It thus involves artificial 
fertilisation outside the human body 
and without sexual intercourse. 
 
Gamete intra-fallopian tube Transfer 
(GIFT)   
This involves the transfer of Oocyte 
and potentiated sperm to the fallopian 
tube with the laparoscope for in vivo 
fertilisation and subsequent 
 
 
implantation and pregnancy.  Although 
this does not also involve sexual 
intercourse, the artificial fertilisation 
occurs in vivo within the human body. 
 
Zygote intra fallopian tube transfer 
(ZIFT)   
This involves the transfer of zygote 
(from fertilisation of Oocytes obtained 
through IVF and potentiated sperm) to 
the fallopian tube with the 
laparascope.  The fertilisation is done 
in vitro before the transfer and without 
sexual intercourse. 
 
Intra uterine Insemination (I.U.I) 
This involves the transfer of 
potentiated sperm using special 
insemination catheters through the 
cervical os into the uterine cavity using 
aseptic technique at the peri- ovulatory 
period which commonly nowadays is 
preceded by a super ovulation 
treatment (with gonadotrophin and 
human chorionic gonadotrophins to 
trigger ovulation) to facilitate release of 
several Oocytes to enhance the 
prospect of conception.  It does not 
involve sexual intercourse but the 
artificial fertilisation occurs within the 
human body (in vivo).  It should be 
noted that insemination of sperm at the 
cervix or unto the cervical os only, with 
whole or partially treated sperm is not 
grouped as Assisted Reproduction 
because it does not alter the inherent 
process leading unto conception. 
 
Other complimentary procedure to 
I.V.F. 
 
(1) Intracytoplasmic  sperm 
injection (ICSI) 
This is a complimentary 
procedure to IVF when there 
are sperm abnormalities of 
either low or deformed 
sperm.  In extreme and 
appropriate cases spermatid 
or yet immature 
spermatozoon obtained from 
the epididymis may be used.  
It involves directly injecting a 
single spermatozoon, unto 
an Oocyte using special 
equipment (The ICSI 
machine).  This is a major 
break-through in the 
treatment of male infertility. 
 
(2) Cryo preservation and 
Transfer of Embryo 
When there are more 
embryos than can be 
transferred in any cycle, the 
excessive embryo are 
cryopreseved by freezing in 
liquid nitrogen.  When the 
frozen embryos are required 
later, they are thawed, and 
transferred into the uterus.   
This helps to prevent 
repeating the stimulation for 
Oocytes again.  At times 
cryopreservation of embryo 
is planned when there are 
contraindications to embryo 
transfer as in fear of severe 
Ovarian Hyperstimulation 
Syndrome (OHSS) or there 
has been an inadequate 
endometrial response. 
 
In Vitro Fertilization and Embryo 
transfer – Basic facts and 
indications  
The first successful IVF in human, was 
in July 1978, leading to the birth of 
Louise Brown in Great Manchester 
City U.K13.  The IVF cycle was 
performed in a natural cycle in which 
the naturally ovulated Oocyte was 
retrieved with the laparoscope under 
G.A.   The IVF was performed 
because Lesley Brown had no tubes 
(which had been removed from two 
previous ectopic) but had normal 
uterine cavity and was normally 
ovulating.    Hence the IVF by passed 
the damaged tubes to obtain the 
 
 
ovulated Oocyte and approximate it to 
the sperm in vitro to obtain the embryo 
which was also transferred under 
general anaesthesia into the uterine 
cavity and subsequently pregnancy 
occurred.  Without IVF Lesley Brown’s 
chance of childbirth was zero.  
 In the early days, IVF was performed 
in natural cycles for women with 
damaged tubes but with normal uterus 
and ovulatory cycles.  Later, it was 
found also helpful in other situations 
with normal tubes but with anovulation.   
A major break through occurred in the 
area of male factor treatment with the 
introduction of the Intracytoplasmic   
sperm injection (ICSI)14.    With the 
technique of pre implantation genetic 
diagnosis and embryo selection, 
healthy babies can now be possible by 
avoiding transfer of embryo with 
genetic disease15, and with embryonic 
stem cell research new areas have 
been opened up16. 
The indication for assisted 
reproduction has now greatly 
expanded to include Oocyte donation 
to treat premature menopause17 
surrogacy for women with damaged 
uterus18, effective endometriosis 
treatment19 and even assessment and 
diagnosis of male factor20. 
 
IVF Procedure 
  At the onset, IVF was performed in 
the natural cycle of the woman and 
several days were often spent 
performing serial laboratory test to 
ascertain when ovulation will occur for 
laparoscopic retrieval.  Often, one 
Oocyte was retrieved for fertilisation 
and therefore one embryo transferred.   
The success rate for this natural cycle 
I.V.F. was less than 5% and required 
tedious laboratory test and clinical skill 
in laparoscopic surgery.   As ovulation 
stimulation drugs were discovered, IVF 
cycles were then stimulated, first with 
Clomiphene citrate but later with 
gonadotrophin in order to generate 
many Oocytes and this was associated 
with much greater pregnancy rate21-23.   
The main problem at this period, with 
stimulated cycles, either with 
clomiphene or gonadotrophins, was 
premature ovulation leading often to 
failed Oocyte retrieval but that was 
resolved with the introduction of 
L.H.RH analogues for pituitary down 
regulation before stimulation with HMG 
24,25.  Currently IVF procedure consist 
of series of steps as explained below. 
 
Controlled ovulation stimulation  
This involves the prior use of LHRH 
analogue for pituitary down regulation 
followed by gonadotrophin injection 
(HMG) aiming for multiple follicular 
growth and development and HCG 
administration at the appropriate time 
as the trigger for ovulation.  This is 
orderwise referred to as super 
ovulation and is a process whereby 
ovulation is deliberately programmed 
in a woman who may have been 
ovulating albeit, irregularly or a woman 
who is Anovulatory.  The aim is to 
stimulate the development of several 
mature follicles from the ovary in order 
to increase the chances of obtaining 
fertilisable eggs26. The use of the 
LHRH analogue prevents premature 
ovulation (which may cause failed 
oocyte retrieval) and the LHRH 
analogue and gonadotrophins are 
administered till day of the HCG 
injection.   The follicular growth is 
currently monitored with trans-vaginal 
ultrasound combined in appropriate 
cases with serum oestrogen 
measurement.27. 
 
Oocyte retrieval  
Once the follicles have reached the 
appropriate size of about 18mm, 
Oocyte retrieval is performed now with 
transvaginal ultrasound using 
ultrasound guided probe in which only 
local analgesia like para cervical block 
is used on out patient basis28. This has 
 
 
made the procedure almost risk free 
and without stress to the patient. 
 
Examination; fertilization and 
incubation 
Once the follicles are retrieved, the 
fluid is examined and the oocytes are 
removed.  The damaged or malformed 
ones are discarded and the others are 
washed and placed in Petri dishes with 
nutrient solution.  After-wards, the 
Oocytes are mixed with the potentiated 
sperm from the male partner and 
equilibrated under laboratory condition 
to allow fertilisation to occur usually 
within 24 hours.  The fertilised Oocyte 
(embryos) are then moved into an 
incubator for a few days to allow the 
cells to divide further. 
Meanwhile, the woman is administered 
with progesterone injection often from 
the day of Oocyte retrieval to prepare 
the uterus for implantation of the 
embryo.  In the older women 
(particularly recipients of oocyte 
donation) the progesterone 
administration may have began from 
the day of HCG administration to the 
oocyte donor to facilitate better 
endometrial preparation in the 
recipient.  Nowadays, instead of 
progesterone injection, macronised 
progesterone pessaries (Gestones), as 
vaginal inserts, are used to minimise 
the risk in injection treatment.  
However, most women cannot tolerate 
the vaginal pessaries because of 
sourness in the vagina from trauma of 
transvaginal needle puncture in the 
first 5-7 days following the Oocytes 
retrieval. This is why there is still 
recourse to the progesterone injection 
commonly in the first one week.   
Thereafter, the progesterone pessary 
is often used for luteal support for the 
next 10 -12 weeks for those who 
achieve clinical pregnancy. 
 
Embryo Transfer 
At the 2-8 cell stage the embryo with 
the best chance of implanting are 
transferred into the uterine cavity 
through the undilated cervical os on 
the 3rd day following oocyte retrieval 
using a special embryo transfer 
catheter.   
This is performed using aseptic 
technique under a sterile operation 
theatre condition.  The procedure 
should be free of any difficulty in the 
identification of the cervical os, 
passage of the transfer catheter 
through the os and release of the 
loaded embryo into the uterine cavity 
which is accomplished without the 
catheter touching the uterine fundus or 
walls.    Difficulty with transfer reduces 
the chances of successful implantation 
and pregnancy.  Although embryo 
transfer is commonly performed 
clinically, the process can be assisted 
with ultrasound to guide the placement 
of the catheter before the release of 
the embryo.  As much as three (but 
less commonly now days) four, 
embryos are transferred to increase 
the chances of implantation especially 
in the older women.  Presently, the 
consensus is for the transfer of one or 
two embryos especially in the young 
woman as a way to reduce the 
common complication of multiple 
pregnancies in IVF29. The remaining 
embryos not transferred are Cryo 
preserved for later use.  Once an 
embryo implants, development 
continues normally in the absence of 
spontaneous abortion or any other 
complication. 
 
Core issues in Human Reproduction 
and role of IVF.   
The core of the reproductive process is 
the union of the sperm and oocytes.  
This union occurs often and normally 
naturally, at the outer third of the 
fallopian tube.  Thus, an essential 
feature of this reproductive process is 
the adequate and appropriate 
 
 
transport of the  oocyte (after release 
from the  ovary)  to the outer third of 
the fallopian tube to be fertilised by the 
sperm which had found its way to the 
outer fluid of the tube after it had been 
deposited into the vagina.  Hence, 
release and transport of the oocyte 
and sperm from the point of release 
are essential steps for the union of the 
oocyte and sperm for fertilization.    
Because, the sperm has a longer 
distance to transverse (from the 
vaginal to the outer third of the 
fallopian tube) motility is thus the most 
important quality required of the sperm 
to succeed in the task of union and 
fertilisation. 
In practical realities, coital frequency is 
the deciding factor for the natural rate 
of pregnancy which means the higher 
coital frequency is associated with 
more pregnancy rate though a coital 
frequency of four or more per week 
may be associated with exhaustion in 
the older couple30.  The idea coital 
frequency is 2-3 times per week evenly 
spaced at every 48 hours apart30.  In 
normal couples, pregnancy rate per 
monthly cycle with idea coital 
frequency is 20-25% but in six month 
pregnancy rate  will increase to 50%, 
in one year it is 90% and in two years 
it is 96%31. In this context, some 
couples fail to conceive by chance and 
even success, naturally or from 
treatment can never be guaranteed31.  
The truth is that the human 
reproduction process is very inefficient 
with as low a pregnancy rate per 
monthly cycle of 25% in the ovulatory 
cycle of a young woman less than 30 
year.   For the older woman, even with 
ovulatory cycle pregnancy rate falls to 
about 12% per month. 
This level of inefficiency is also greatly 
extended to poor conception rate in 
couples who had successful treatment 
for single cause of infertility with the 
conventional method, as shown in the 
table. 
Type of single treated infertility  Conception rate as percentage of couple   
Causal factor      
 1 Cycle           6 Cycles             12 Cycles 
 
1.    Anovulation  
       (Amenorrhea; Oligomenorrhea;     12%      65%   80% 
      or  normal  periods). 
 
2.    Unexplained infertility      10%      40%    55% 
 
3.    Sperm Disorder with Normal 
        count         5%       10%  20% 
 
4.     Sperm Disorder with low count       1%        3%     6% 
 
5.     Tubal Damage         6%         10%     18% 
 
 
(Cummulative conception rate from conventional management in couple with a single 
cause of infertility.  Adopted from Hull MGR et al ’85 (32). 
 
As shown from the table above, in all 
of the causal factors, the best 
conception rate of 12% and 10% was 
from Anovulatory and unexplained 
infertility in one cycle while all other 
factors in 1 cycle have a near chance 
pregnancy rate of 6% or less32 
 
 
It is quite obvious that left with the 
conventional infertility management 
methods, the inefficiency of the human 
reproduction capacity cannot be 
improved much even with the best of 
treatment.   For some of the causal 
factors like sperm disorders and tubal 
damage, conventional infertility 
treatment does not offer better than 
chance occurrence of pregnancy per 
cycle; hence the need for Assisted 
Reproduction Technologies like IVF 
and ET.   The technique of IVF allows 
a by-pass of some (if not all) of the 
insurmountable infertility causal factors 
by the conventional methods to allow 
pregnancy and child birth where order 
wise the chances of birth is zero.    
The problems preventing the union of 
oocytes and sperm in the natural 
setting is by-passed by the super 
ovulation, oocyte retrieval, fertilisation 
and incubation and subsequently the 
Embryo transfer. In good IVF centres, 
the pregnancy rate equates to the 
natural pregnancy rate per monthly 
ovulatory cycle of 25%.  At times the 
IVF success rate is much higher than 
25% because of multiple embryo 
transfer which allow the conception 
rate to surpass the natural rate which 
often is monofollicular and uni-embryo 
implantation33; 34.  There is no other 
method of infertility treatment currently, 
that can achieve this same pregnancy 
rate per month of 25% apart from IVF.   
Like other methods of treatment, 
repeated IVF has a cumulative 
success rate which is virtually the 
same, 25% or more, for every attempt 
for at least the first 6-8 repeat cycles35 
This means a higher success rate with 
repeat IVF attempt. 
 
Problems and Risks of IVF  
 
Problems 
1. Technique is complex, 
expensive and stressful.   
The cost is $10,200 in USA 
per cycle and in Britain, it is 
four to five thousand pound 
sterling per cycle.  The high 
cost is due to the high tech 
nature of the equipments, 
cost of the drugs, and 
media, and manpower cost. 
2. The 25% pregnancy rate per 
cycle implies there is 75% 
failure rate.  However, it is 
often not recalled that the 
natural pregnancy rate per 
month for a young ovulatory 
woman under 34 years is 
similarly 25% with 75% as 
failure rate. 
 
Complications of IVF and ET 
1. Ovarian infections,   Ovarian 
rupture though rare, may occur 
2. Ovarian Hyperstimulation 
syndrome (OHSS).  This may 
occur in (0.6 – 14) % of IVF 
treated population36.  It is often 
a serious life threatening 
complication.  The condition 
commonly occurs with the use 
of LHRH analogues and HMG 
followed by H.C.G. as trigger for 
ovulation.   Polycystic ovary and 
administration of HCG appear 
to be a major predisposing 
factor for development of the full 
blown OHSS.  Hence 
preventing OHSS at times 
involves non use or reduction in 
the dose of HCG or astute 
careful retrieval of all the 
oocytes followed by fertilisation 
and then cryopreservation of 
the embryo for transfer later in a 
non-stimulated cycle when the 
OHSS has subsided37. In 
clinical practice, the 
predisposing factors may have 
been missed or were absent in 
the particular individual.  The 
full blown OHSS disease many 
manifest (in the severe form) 
anytime from the 2nd or 3rd or 
 
 
even 5th day after embryo 
transfer with abdominal pain, 
abdominal distension, vomiting 
and respiratory difficulty 
associated with high packed 
volume level.  Often, astute and 
aggressive treatment is required 
to forestall the disease process 
hence it is always better 
prevented by all means.  
3. Risk of G. A., where it is used 
for any of the IVF procedure. 
4. Spontaneous abortion: This 
tends to be higher following IVF 
pregnancies due to factors like 
poor embryo malimplantation 
and aging of the woman. 
5. Ectopic pregnancy and at times 
heterotrophic pregnancy.  This 
is often a serious problem that 
requires urgent attention  
6. Multiple pregnancy: This 
complication occurs in almost 
30% of IVF pregnancies.  Often 
due to transfer of several 
embryos as a way to ensure 
implantation and pregnancy.   
Approach nowadays is to 
transfer only one embryo for the 
young woman and not more 
than two in the older woman. 
7. Preterm delivery: This may be 
due to the multiple pregnancy or 
gross anomaly in the fetus.  
Adequate preparation to handle 
this problem with the provision 
of an effective and efficient 
neonatal intensive care unit at 
I.V.F. centres is important as a 
solution to this problem. 
 
Pattern and trend of infertility world 
wide 
The level and pattern of infertility vary 
greatly depending on the prevalence of 
“Core infertility” (biological variation in 
chromosomal, congenital and 
endocrinological abnormalities) and 
“acquired infertility” (geographical 
variation in infectious, environmental 
and occupational factors)38;39.    Apart 
from this; the reports of causes and 
outcome of infertility treatments is 
highly variable because of the lack of a 
standard protocol for the investigation 
and treatment which makes it difficult 
to compare results with respect to 
patterrn; differences and similarities.  
The WHO produced a standard 
protocol for the investigations of the 
infertile couple40 which was tested in 
8,456 couples from 34 centres in 25 
countries world wide including four 
centres in Africa.  The protocol 
standardised procedure, definitions 
and identification of the factor that are 
important in assessing the fertility 
status in both the males and females.    
The results of the study which was 
published in 1985 showed the pattern 
and trend of infertility world wide in the 
developed and developing countries41. 
African countries amongst all other 
developing countries were found to be 
peculiar in several respects, viz: 
i. African women had infertility 
for longer duration before 
consulting for assistance.  
ii. African women were much 
younger than their male 
partners almost like the men 
were marrying women, of 
the age of their 
grandchildren. 
iii. African women had much 
higher past history of S.T.D. 
and prior pregnancy 
complication. 
iv. African women had much 
higher secondary infertility 
than primary infertility. 
The conclusion from the study was 
that infertility in African countries, were 
essentially due to sexually transmitted 
diseases and complications following 
induced  abortions and poor maternity 
care which  are all preventable by 
simple strategies42. 
It was then recommended that 
approach to infertility management in 
 
 
the African countries should be 
preventive.    The issue of Assisted 
Reproduction Technology (ART) as 
treatment for infertility was 
emphasised as being of the least 
priority importance in infertility 
management. 
 
Current Status of infertility in 
developing countries 
The W.H.O. study published in 1985 
involved four African countries in which 
842 couples with different social and 
cultural background were evaluated.  
The studies were performed in a poly- 
clinic setting in which the same areas 
at the participating centres were used 
for various other purposes other than 
for the management of the infertility 
alone.  In contrast, several of the other 
participating centres in Europe but to a 
lesser extent in Asia and Latin 
America, managed the infertility couple 
in their studies from centres that were 
dedicated for infertility because of the 
high premium on infertility as a 
reproductive health index.  Such 
dedicated infertility programmes are 
uncommon in most African countries 
and certainly did not exist in all the 
African centres who participated in the 
W.H.O. studies, even though there is a 
huge burden of infertility in the 
gynaecological practice. 
This would suggest that the findings in 
the socio-cultural and epidemiological 
correlates of the infertility in the 
W.H.O. studies may not   have been 
truly comparable; unless African 
studies were performed in similar 
dedicated infertility programme.   This 
is perhaps why African countries had 
strikingly different infertility findings as 
highlighted in the W.H.O. study.  
Perhaps, the findings from the WHO 
study if performed in similar dedicated 
fertility centre as in Europe etc, may 
have found other infertility causes that 
are not preventable by the 
recommended strategy.    The WHO 
recommendation of prevention as the 
most cost effective approach to 
infertility management in African 
countries would mean, that the 
prospect of infertility management in 
contemporary times of concurrent 
preventive and curative approach 
including with ART will never gain 
government support, for public 
funding.   This is the reason for low 
public spending on infertility 
management in the developing 
countries.   The findings from studies 
of the socio-cultural and 
epidemiological factors of infertility 
from a dedicated program of infertility 
in Nigeria did not corroborate several 
aspects of the prior WHO study of 
198541.  Thus, the prospect of infertility 
management in a developing country 
attaining the status as in developing 
countries is best illustrated by the 
experience at a unique programme for 
infertility management in a University 
hospital in Nigeria. 
 
A University hospital based 
infertility programme in Nigeria 
The infertility programme is part of the 
department of obstetrics and 
gynaecology of the University of Benin 
Teaching Hospital Benin City, Edo 
State, Nigeria and is called the Human 
Reproduction Research Programme 
(H.R.R.P.).    The programme has its 
own site building with consulting 
rooms, laboratories and administrative 
office space.  Consultation for infertility 
is daily during the working period and 
the programme has its own Nurses, 
Laboratories Scientist, Administrative 
and Support staff.     Since the 
Programme has its own building with 
ample space, clients are received at 
the centre as couples and given 
assurance of strict confidentiality of 
information even between consorts.  
After the initial consultation, follow-up 
visit are tailored for the convenience of 
the couples without the usual 
 
 
institutional rigidity but within the 
working period.  Good rapport was 
commonly established between the 
couple and clinic staff after one or two 
visit with same staff (Nursing and 
Medical) unlike consultation in the 
routine gynaecology clinic where 
clients encounter different staff at each 
visit.   This management approach 
encouraged the women to volunteer 
confidential information and truth about 
their age, parity and husband 
occupation. 
The main tool for the investigation, 
classification and diagnosis of infertility 
was the World Health Organisation 
(WHO) format for the investigation of 
the infertile couple as published in 
1984 by Rowe and Farley40.  All the 
couples were assessed by the 
consultants and by specially trained 
Nurses.  After full investigation using 
the WHO protocol, diagnosis was 
established and the conventional 
treatment of infertility provided.  The 
couples were followed up thereafter for 
pregnancy outcome.    The results 
from  the programme  assessed  
whether the local pattern  of  infertility 
are a reflection of the WHO study over 
2 decades ago on which findings and 
recommendation on infertility 
management, strategy for African 
countries was based. 
 
Deduction from the University 
hospital based infertility 
Programme in Nigeria  
The outcome of 10 years of infertility 
management involving almost 2000 
consecutive couples at the programme 
was recently published43.  Although 
findings suggest infertility pattern 
similar to the prior WHO study, there 
are several differences.  The Nigeria 
woman was not so much younger than 
her husband, the secondary infertility 
rate was 85.7% with primary infertility 
rate of only 14-3%  and complications 
of induced abortions contributed the 
highest to tubal blockage, (the 
commonest female  causal factor) 
followed by vaginal deliveries attended 
by unskilled persons in unhygienic 
environment. These are all very 
different from the prior WHO study.  It 
also showed that there are infertility 
causes that are unpreventable. 
The differences in this study and 
others is due to the assurance of 
confidentiality and rapport established 
between patients and programme staff 
which led to the disclosure of the truth 
about the women age, parity and 
details of the mode and place of 
delivery.  Culturally Nigerian women 
reduce their age; deny prior abortion 
and deliveries especially in previous 
relationships (because they must be 
seen as young and innocent of prior 
sexual relationship) and do not 
disclose the mode and place of 
delivery.  The rapport and 
confidentially essential for disclosure 
may not have been possible in the 
environment described in the WHO 
and other studies which may explain 
the marked discrepancy  between this 
study and  other studies of infertility. 
The pregnancy rate of 40.1% occurred 
mainly from the treatment of female 
factors alone and spontaneous 
pregnancy in 7.5% attributable to the 
education and counselling on coital 
timing provided at the centre.  
Pregnancy rate was very poor in the 
female factors requiring surgery, in 
several of the moderate to severe 
male factor alone but particularly in 
couples with both male and female 
factors. 
Thus, in almost 60% of the study 
population, the infertility program 
(representing the highest 
concentration of resources in a 
developing economy for most types of 
infertility treatment) could not help the 
couple achieve pregnancy and further 
treatment improvement is impossible 
with the conventional method 
 
 
available.  This is principally because a  
sizeable proportion of the infertile 
couples had both female and male 
factors and a sizable proportion with 
female factors required surgical 
treatment that were associated  with 
poor outcome.  These, are intractable 
to conventional infertility treatment 
method and are best treated with 
Assisted Reproduction Technology 
(ART). 
 The capacity to treat aspect of 
infertility unresponsive to conventional 
methods would improve results and 
therefore justify the investment.  
Hence the data from this study is a 
case for implementing ART as a key 
element in future infertility research 
and treatment.  This study outcome is 
proof that conventional infertility 
treatment method has insufficient 
capacity for treatment of the majority of 
infertile couple in our environment.   
 
Preventive versus Curative 
approaches to infertility 
management in a developing 
economy 
The issues raised in the 
recommendations of ART as back up 
infertility treatment deserve further 
discussion. The data from our study 
confirm that secondary infertility is the 
main issue and can be reduced by 
preventive strategies like access to 
effective family planning, improved 
maternity care and Health education to 
reduce risky behaviour that can cause 
S.T.D.   Not only is prevention cheap 
but the strategy will confer several 
other benefits to women’s right and 
society, hence radical proponents of 
preventive strategy for infertility 
management, recommend total 
commitment of resource only to 
prevention44-46 . This radical stance is 
untenable in contemporary times, 
because in the case of disease control 
with HIV/AIDS there is free distribution 
of antiretroviral drugs to HIV Positive 
patients (instead of allowing those 
afflicted with HIV Virus to progress to 
AIDS and die) in addition to huge 
money spent on the campaign to 
promote   the use of condom as 
prevention for the disease47. 
No matter the degree of coverage of 
any preventive strategy it will not apply 
to the several people who already now 
are infertile and also it is not all 
infertility cause that are preventable48.   
A much better approach is the 
moderate view of infertility prevention 
advocating that priority should be 
accorded prevention, but adequate 
resources should be directed to 
curative measures to benefit the 
population already afflicted with 
infertility49-51. 
The other issue against curative 
measures for infertility is the over 
population issue because there is the 
demographic paradox that countries 
with the highest overall fertility rate are 
also those in which the prevalence of 
secondary infertility is highest52.  There 
is therefore strong argument against 
infertility treatment especially with 
extension to ART because it would be 
wrong use of scare resources and 
worsening of the world population 
crisis.   This over population as a 
reason to neglect infertility is wrong 
logic seeking for the few infertile 
women to bears the burden of world 
over- population in which their 
individual liberty for child wish is 
unjustly denied51,53,54.   More over, 
such an approach is highly oppressive 
of those who are infertile as there are 
better ways of population control which 
do not infringe upon peoples’ right like 
educating women, providing 
contraception and safe abortion 
service47.    More recently, it was 
suggested that the over population 
problem of the world is not any more 
due to high fertility rate (whether in the 
developed or developing countries) but 
due to increased life expectancy 
 
 
causing population growth by 
population aging54. 
It is therefore reasonable to suggest 
that for the developing economy the 
infertility management approach 
should be concurrent preventive and 
curative.  The data from our study at 
the infertility programme has now 
defined the content of effective 
curative infertility management to 
include establishing infertility 
programme with competence for ART 
treatment because majority of the 
infertility causal factors are intractable 
to conventional treatment. Certainly 
the social, emotional, physical and 
economic consequences that infertile 
couple (and in particular women) face, 
justifies investing in treatment options 
like ART in developing countries56;57  
This was our impetus for the up 
grading of the infertility programme to 
include capacity for ART services. 
 
IVF in Public Hospital in Nigeria:  
Practice, problems and prospects  
After almost two decades of infertility 
management at the infertility 
programme, it was found that almost 
60% of the couple could not achieve 
pregnancy.  This is because of causal 
factors which are intractable to 
conventional methods occurring singly 
or in combination.   In order to improve 
the treatment outcome, the 
programme was upgraded to include 
facilities for Assisted Reproduction 
technology.  The programme site 
building was expanded to provide 
more space for office hysteroscopy, 
ultrasound with transvaginal probe and 
full in vitro fertilization and embryo 
transfer (IVF and ET) equipments and 
intracytoplasmic sperm injection (ICSI) 
machine.  Full ART services including 
intra uterine insemination (I.U.I) and 
IVF and ET with ICSI began June 
2007. 
IVF and ET with ICSI was offered to 
the couple who could not achieve 
pregnancy by the conventional 
method.  The IVF and ET approach 
involved the standard practise of 
pituitary down regulation, followed by 
super ovulation with ganodotrophin 
using the long protocol during which 
follicular response was assessed by 
regular transvaginal ultrasound.  
Human Chronic Gonadotrophin (HCG) 
was administered for ovulation 
induction when follicles of at least 
18mm diameter were obtained and 
Oocyte retrieval by the transvaginal 
route performed 35-36 hours after the 
HCG.  The Oocytes were assessed by 
the embryologist, fertilised with the 
previously potentiated sperm and 
resulting embryo transferred on the 
third day trans- cervically using 
standard embryo transfer catheters.  In 
the appropriate cases ICSI was 
performed when there was significant 
male factor.  The IVF method followed 
the standard Western method as 
variously published58-61. 
The IVF service delivery was done in 
batches of 30-40 couples as a 
deliberate policy and involved the prior 
synchronisation of the menstrual cycle 
of the women at times across one to 
three cycles with sequential oestogens 
and progestogens.  This allowed the 
focalisation of all the manpower and 
infrastructure for the given period of 
Oocyte retrieval, embryo culture and 
transfer.  It also allowed the 
concentration of work for a stipulated 
period for appropriate manpower 
deployment.  This way, the muted 
fears of unstable light and water and 
poor staff motivation in the public 
hospital system was resolved because 
during any IVF run adequate staff and 
stable infrastructure is assured. 
The outcome of the first year 
experience with IVF in a public hospital 
has been collated and is being 
published elsewhere 62.  There were 
150 couples handled in 5 batches in 
which there were about 30 couples per 
 
 
batch.    The mean age of the women 
was 36 years witha range of 32-44 
years.  The mean parity was 0.7 and 
mean duration of infertility was 10.5 
years.   The women had several 
previous failed treatment mainly 
surgery (see table 2) and the 
commonest indication for the IVF was 
tubal disease and combined male and 
female factors.      The clinical 
pregnancy rate was 28% per cycle in 
which there have been 8 deliveries so 
far. This result is comparable to other 
I.V.F  centres63 -65.  The most severe 
problem encountered was severe 
Ovarian Hyperstimulation syndrome 
(OHSS) which occurred in two women 
in the series and resolved with 
standard management as described by 
Lainas 200265. 
Thus IVF Service delivery in a public 
hospital system in Nigeria is 
practicable and effective as a back up 
for infertility cases that are intractable 
to conventional treatment as in almost 
60% of the infertile population.  For the 
women who achieve pregnancy by this 
method there were are no other ways 
to assist them and hence ART is a 
worth while investment even in our 
resource limited environment.  The IVF 
and ET programme adopted the full 
Western style approach and achieved 
a pregnancy rate that is comparable to 
other IVF centres world wide.  This fact 
has now broken the myth   that IVF is 
not possible in a public hospital system 
as suggested by other workers67,68.  
The strategy of batching allows   the 
optimisation of the manpower and 
focused infrastructural support during 
an IVF run.  Aside from this, batching 
also allowed the sufficiently large 
number of couples such as 40 as in 
our case in a single run which is useful 
for research and teaching the IVF 
knowledge.  Having now established 
the structure for IVF at the programme, 
the next stage is to assess how the 
cost of the IVF can be reduced to 
make it more affordable.  This will 
involves reduction of cost of drugs, 
equipments and substantial reduction 
in the chargeable fee by the hospital 
as advocated by other workers50, 63,64. 
It is when the cost of IVF is affordable 
that a truly comprehensive curative 
infertility treatment can be said to be 
available and comparable to standard 




Infertility in developing countries is 
pervasive and has devastating 
consequences for the couple 
especially the woman who culturally is 
held culpable for the cause of the 
infertility.   Since childbearing is the 
sole purpose of marriage in these 
settings, infertility or childlessness 
leads to societal disharmony, divorce, 
violence, suicide and other 
psychological disorders.  It is in every 
way a disease burden that deserves 
priority attention because of the 
widespread effect on society and the 
community.  This is in contrast to 
infertility in the Western society where 
the effect on society is minimal if at all, 
and yet infertility treatment at whatever 
cost including ART is never denied 
anyone who required it. 
  In the developing economy, infertility 
management has been advised to 
adopt the much cheaper preventive 
approaches because of limited funds 
and burden of over population.  
Assisted reproduction technology 
(ART) for infertility management, is 
said to be wasteful and not practicable 
because of poor public infrastructure 
low man power capacity and low staff 
morale.  Recent studies have shown 
that in 60% of infertile population in 
some developing economy, the 
effective treatment is ART or most 
perhaps will never achieve conception.    
The report of IVF in a public hospital 
with a comparable pregnancy rate like 
 
 
others IVF centres world wide confirms 
that IVF in a public hospital setting is 
practicable and worth the investment 
in a developing economy.  What 
remains is the approach for IVF cost 
reduction to make it affordable.  This is 
the only way that contemporary 
concept of infertility management will 
have prospect in a  developing 
economy to be practiced appropriately 
in the context of the preventive and 
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